apogenix.com

Apogenix Ag

apogenix ag's email is contact@apogenix.com and apogenix ag's phone number is +49 6221 58608-0 .

Apogenix is a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases. The compound´s mechanism of action is either based on the targeted modulation of the programmed cell death (a.k.a. apoptosis - ἁπόπτωσισ is used in Greek to describe the ''falling off'' of leaves from trees) or on the inhibition of tumour cell growth. The lead product candidate of the company, APG101, is currently in a controlled phase II proof of concept study with GBM patients (GBM: Glioblastoma multiforme).
View Top Employees for apogenix ag
img Website apogenix.com
img Industry Biotechnology
img Location Germany
Founded 2005
HQ Im Neuenheimer Feld 584
Phone +49 6221 58608-0
Email contact@apogenix.com
img Funding 38,000,000 EUR
img Website
img Industry Biotechnology
img Employees 37
img Founded 2005
img LinkedIn
img HQ Im Neuenheimer Feld 584
img Phone +49 6221 58608-0
img Email contact@apogenix.com
img Funding 38000000

Top Apogenix Ag Employees